Dr. Jamie Deckoff Jones’ blog came out with a post on Sunday, Oct 2 – “X Rx Square One” – stating that “the entire WPI research program has been closed by the Institute’s CEO, and the facility is now locked down.”
Supporters on the WPI Facebook page were confused all-around and found no news on the WPI site.
Then Monday, Oct 3, at about 1:30 PM Pacific time, WPI management posted this comment on Facebook:
“The Whittemore Peterson Institute is announcing the departure of Dr. Judy Mikovits from WPI. We wish to thank her for her previous work and commitment. The WPI remains committed to a comprehensive research program. Our research team and program remains active, and our lab open to authorized employees. We will continue the critical work of finding answers to M.E. and related diseases. “We will use the opportunity created by the departure of Dr. Mikovits to do a full evaluation of our research lab and current research projects. WPI is dedicated to the highest standards in research and patient care, and to advocating for the patients, families and caregivers we exist to serve.”
– Michael Hillerby, Whittemore Peterson Institute
Also Monday, Wall Street Journal ME/CFS reporter Amy Dockser-Marcus posted this article – “Scientist Who Led XMRV Research Team Let Go” – stating that she (Dockser Marcus) had seen a copy of WPI CEO Annette Whittemore’s letter to Dr. Mikovits, to the effect that “Mikovits was terminated after refusing Whittemore’s direct request that cell lines be turned over to another scientist at the Institute who wanted to do research on them.”
Tuesday: Dr. Deckoff-Jones commented in discussion of her Tues, Oct 4 blog post,
“No Good Deed Goes Unpunished” that “if anyone would like to reach Dr. Mikovits, she welcomes your emails. Her email address is firstname.lastname@example.org“
Reportedly Dr. Mikovits retains her research grant and intends to continue her research – elsewhere. Meanwhile many speculate about the situation with little to go on, and the ME/CFS world will stay tuned.